Gastrointestinal Drug Market is Expected to Grow at a CAGR of 4.5%

Pune, India, June 19, 2017 /MRFR Press Release/- Market research future published a half cooked research report on global Gastrointestinal Drugs market. The Gastrointestinal Drugs market is expected to grow over the CAGR of around 4.5% during the period 2017 to 2023.

Gastrointestinal diseases cover a wide range of diseases. Approximately 6% of total European population is suffering from GI diseases. Beside the common diseases like abdominal pain, gas, diarrhea, many chronic diseases like Crohn’s disease and ulcerative colitis, celiac disease, diverticulitis, irritable bowel syndrome helps in contributing a huge share in the GI drug market. Factors like increasing investment in research activity, growing population are responsible for increasing the market in this region. Beside this unhygienic food and improper diet are responsible for causing many GI diseases. Whereas incorrect self-diagnosis and introduction of may misbranded and spurious drug in the market can be responsible for hampering gastrointestinal market growth in Europe and Middle East and Africa.

Europe, Middle East and Africa Gastrointestinal Drugs Market Share, by Disease type

Segmentation

Europe, Middle East and Africa Gastrointestinal Drugs market has been segmented on the basis of Drug Category they are segmented into acid neutralizers, laxatives and antidiarrheal, antiemetic, anti-inflammatory drugs and other. Acid neutralizers are further sub segmented into antacids, H2 antagonists, proton pump inhibitors and others. By route of administration the market is segmented into oral, parenteral and rectal. By disease type they are segmented into gastroesophageal reflux disease, inflammatory bowel disease and other. By end user hospital pharmacies, retail pharmacies and other.

Gastroesophageal reflux disease and inflammatory bowel disease are the two major diseases for contributing a major amount of GI drug market. About 6 million people in UK and 8.2 million people in Germany are suffering from gastroesophageal reflux disease. Around 35% of total market id dominated by this disease.On geographical basis, Europe is second largest market for GI drugs globally. Middle East and Africa market contribute least in GI drugs market due to limited development of healthcare sector. Poor infrastructure and limited manufacturing companies in this area has led the market to grow at slow and steady rate. While on other hand Europe has a growing market. Many European countries like Germany, UK, France and many more invest a huge amount of money in development and introduction of new gastrointestinal medication. 

In 2016, Europe, Middle East and Africa gastrointestinal drug market was approximately 15 million and is expected to grow at CAGR of 4.5 % during 2017-2023.Diseases like inflammatory bowel disease and Irritable bowel syndrome lack the absolute treatment. There is no drug available in the market assuring 100% relief of this diseases. This provide a wide range of opportunities for manufacturers to development there market in this region and so many major manufacturer are investing in research and development of GI drugs.Gastrointestinal drug market is fragments with various different companies in local regions. 

Some of the major players in medical rubber and balloon market are: AstraZeneca Plc. (UK), Johnson & Johnson (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals Inc. (US), Sanofi Ltd. (France), Valeant (US), Abbott Laboratories (US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), AbbVie Inc. (US), Janssen Biotech (US), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany).

Figure 2- Major Players in Gastrointestinal Drug Market

Access Full Details on Gastrointestinal Drug Market Research Report

About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand,

Market Research Future

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com